1-3 of 3
Huseyin Bekoz
Close
Sort by
Journal Articles

Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients

Omur Sevindik, Hülya Bilgen, Istemi Serin, Elif Melek, Volkan Karakuş, Kübra Çerçi, Yaşa Gül Mutlu, Berrin Balik Aydin, Sevil Sadri, Hüseyin Beköz, Leylagül Kaynar
Journal: Blood
Blood (2022) 140 (Supplement 1): 12803–12804.
https://doi.org/10.1182/blood-2022-168558
Published: 2022
Journal Articles

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Burhan Ferhanoglu, Zafer Gulbas, Ant Uzay, Muhit Özcan, Fahir Ozkalemkas, Mehmet Sinan Dal, Hakan Kalyon, Olga Meltem Akay, Burak Deveci, Huseyin Bekoz, Omur Gokmen Sevindik, Tayfur Toptas, Asu Fergun Yilmaz, Derya Koyun, Nihan Alkis, Elif Birtas Atesoglu
Journal: Blood
Blood (2022) 140 (Supplement 1): 6704–6705.
https://doi.org/10.1182/blood-2022-165385
Published: 2022
Journal Articles

Adult Case Series of Extramedullary Relapsing Acute Myeloid Leukemia (AML) after Allogeneic Stem Cell Transplantation in Whom a Rapid Response and a Reasonably Long Remission Could be Achieved with Gemtuzumab Ozogamycin (GO)

Omur Gokmen Sevindik, MD, Ali Ihsan Gemici, Furkan Selim Usta, Asli Çakır, Sevil Sadri, MD, Hüseyin Beköz, Fatma Deniz Sargın
Journal: Blood
Blood (2019) 134 (Supplement_1): 5129.
https://doi.org/10.1182/blood-2019-126195
Published: 2019